Clinical trial
Topiramate for Treatment of Patients With Borderline Personality Disorder and…
NCT00463775 · Elizabeth Ralevski, Other · Withdrawn
Key facts
| NCT number | NCT00463775 |
|---|---|
| Title | Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence |
| Official title | Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence |
| Lead sponsor | Elizabeth Ralevski, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alcohol Dependence, Borderline Personality Disorder |
| Intervention type | Drug |
| Interventions | Topiramate |
| Enrollment | 0 |
| Start date | Mar 1, 2007 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Apr 20, 2007 |
| Last update posted | Jan 31, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: